St. Mark's Hospital - September 01, 2016

On August 17, 2016, St. Mark’s Hospital laboratory began offering a multiplex PCR panel for the detection of 6 bacteria, 7 viruses, and 1 fungus from a single CSF specimen providing results within 1-2 hours using the rapid molecular identification methods of the FilmArray Meningitis/Encephalitis (ME) Panel from BioFire Diagnostics which is now FDA approved and provides overall sensitivity and specificity of 94.2% and 99.8% respectively. This test can significantly reduce the time to appropriate pharmacotherapy, improving patient outcomes and reducing long-term healthcare costs. This is a reflex test that will be performed on all CSF specimens with greater than 5 WBC/mm3. If this test is indicated in a situation when reflex criteria have not been met, test can also be ordered as “ME Panel” in Epic.

Questions? Call Joe Wallis, MT, at (801) 268-7189 or joe.wallis@mountainstarhealth.com. The panel tests simultaneously for the following pathogens:

  • Escherichia coli K1
  • Haemophilus influenza
  • Listeria monocytogenes
  • Neisseria meningitides
  • Streptococcus agalactiae
  • Streptococcus pneumoniae
  • Cytomegalovirus
  • Enterovirus
  • Herpes simplex virus 1 (HSV-1)
  • Herpes simplex virus 2 (HSV-2)
  • Human herpesvirus 6 (HHV-6)
  • Human parechovirus
  • Varicella zoster virus (VZV)
  • Crytococcus neoformans/gatii

Other Articles

September 1, 2016
An upgrade to our electronic medical record is scheduled to occur on Saturday, November 12th.
Previous Post
September 1, 2016
The date has been changed for the medical staff meeting originally scheduled in late October.
Next Post